(1E,4E)-ethyl 2-amino-8-(pyridin-2-yl)-3H-benzo[b]azepine-4-carboxylate | 1268163-11-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (1E,4E)-ethyl 2-amino-8-(pyridin-2-yl)-3H-benzo[b]azepine-4-carboxylate
• 英文别名: ethyl 2-amino-8-pyridin-2-yl-3H-1-benzazepine-4-carboxylate
• CAS: 1268163-11-6
• 化学式: C₁₈H₁₇N₃O₂
• 分子量: 307.352
• InChiKey: MWXRSRKZULBEHT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  77.6
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS
  申请人：Howbert James Jeffry

  公开号：US20110118235A1

  公开（公告）日：2011-05-19

  Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.

  提供了用于调节Toll样受体TLR7和/或TLR8信号传导的组合物和方法。这些组合物和方法可用于治疗或预防疾病，包括癌症、自身免疫疾病、传染病、炎症性疾病、移植排斥和移植物抗宿主病。
• Substituted Benzoazepines as Toll-Like Receptor Modulators
  申请人：ARRAY BIOPHARMA, INC.

  公开号：US20140142086A1

  公开（公告）日：2014-05-22

  Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.

  提供了对通过Toll样受体TLR7和/或TLR8信号传导进行调节的组合物和方法。这些组合物和方法在治疗或预防疾病方面有用，包括癌症、自身免疫疾病、传染病、炎症性疾病、移植排斥和移植物对宿主病。
• US8524702B2
  申请人：——

  公开号：US8524702B2

  公开（公告）日：2013-09-03
• US9242964B2
  申请人：——

  公开号：US9242964B2

  公开（公告）日：2016-01-26
• [EN] SUBSTITUTED BENZOAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS<br/>[FR] BENZOAZÉPINES SUBSTITUÉES COMME MODULATEURS DES RÉCEPTEURS DE TYPE TOLL
  申请人：VENTIRX PHARMACEUTICALS INC

  公开号：WO2011022509A2

  公开（公告）日：2011-02-24

  Provided are compositions and methods useful for modulation of signaling through the Toll- like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.